Characteristics of a Carbapenem-Resistant Acinetobacter baumannii Strain Causing Community-Acquired Pneumonia in a Young Healthy Women

References

• Squire MS, Townsend HA, Actis LA. The influence of blue light and the BlsA photoreceptor on the oxidative stress resistance mechanisms of Acinetobacter baumannii. Front Cell Infect Microbiol. 2022;12:856953. doi:10.3389/fcimb.2022.856953
   PubMed Web of Science ®Google Scholar
• Mea HJ, Yong PVC, Wong EH. An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation. Microbiol Res. 2021;247:126722. doi:10.1016/j.micres.2021.126722
   PubMedGoogle Scholar
• Nguyen M, Joshi SG. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. J Appl Microbiol. 2021;131:2715–2738. doi:10.1111/jam.15130
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Timsit JF. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis. 2019;32(1):69–76. doi:10.1097/QCO.0000000000000518
   PubMed Web of Science ®Google Scholar
• Chen CH, Wu PH, Lu MC, Ho MW, Hsueh PR. Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020. Int J Antimicrob Agents. 2023;61(2):106707. doi:10.1016/j.ijantimicag.2022.106707
   PubMed Web of Science ®Google Scholar
• Diep DTH, Tuan HM, Ngoc KM, et al. The clinical features and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii infections at a tertiary hospital in Vietnam. J Glob Antimicrob Resist. 2023;33:267–275. doi:10.1016/j.jgar.2023.04.007
   PubMed Web of Science ®Google Scholar
• Eze EC, Falgenhauer L, El Zowalaty ME. Draft genome sequences of extensively drug resistant and pandrug resistant Acinetobacter baumannii strains isolated from hospital wastewater in South Africa. J Glob Antimicrob Resist. 2022;31:286–291. doi:10.1016/j.jgar.2022.08.024
   PubMed Web of Science ®Google Scholar
• Stracquadanio S, Bonomo C, Marino A, et al. Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability. Microbiol Spectr. 2022;10(5):e0234722. doi:10.1128/spectrum.02347-22
   PubMedGoogle Scholar
• Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;11(1):10. doi:10.3390/pathogens11010010
   PubMedGoogle Scholar
• Kasperski T, Romaniszyn D, Jachowicz-Matczak E, Pomorska-Wesołowska M, Wójkowska-Mach J, Chmielarczyk A. Extensive drug resistance of strong biofilm-producing Acinetobacter baumannii strains isolated from infections and colonization hospitalized patients in Southern Poland. Pathogens. 2023;12(8):975. doi:10.3390/pathogens12080975
   PubMed Web of Science ®Google Scholar
• Shadan A, Pathak A, Ma Y, Pathania R, Singh RP. Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection. Front Cell Infect Microbiol. 2023;13:1053968. doi:10.3389/fcimb.2023.1053968
   PubMed Web of Science ®Google Scholar
• Denissen J, Reyneke B, Waso-Reyneke M, et al. Prevalence of ESKAPE pathogens in the environment: antibiotic resistance status, community-acquired infection and risk to human health. Int J Hyg Environ Health. 2022;244:114006. doi:10.1016/j.ijheh.2022.114006
   PubMed Web of Science ®Google Scholar
• Riddles T, Judge D. Community-acquired, bacteraemic Acinetobacter baumannii pneumonia: a retrospective review of cases in Tropical Queensland, Australia. Trop Med Infect Dis. 2023;8(8):419. doi:10.3390/tropicalmed8080419
   PubMedGoogle Scholar
• Liu C, Chen K, Wu Y, et al. Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China. Emerg Microbes Infect. 2022;11(1):1730–1741. doi:10.1080/22221751.2022.2093134
   PubMed Web of Science ®Google Scholar
• Mu X, Wang N, Li X, et al. The effect of colistin resistance-associated mutations on the fitness of Acinetobacter baumannii. Front Microbiol. 2016;7:1715. doi:10.3389/fmicb.2016.01715
   PubMed Web of Science ®Google Scholar
• Ten KE, Muzahid NH, Rahman S, Tan HS, Leung SY. Use of the waxworm Galleria mellonella larvae as an infection model to study Acinetobacter baumannii. PLoS One. 2023;18(4):e0283960. doi:10.1371/journal.pone.0283960
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiang T, Bao D, et al. Global population structure and genomic surveillance framework of carbapenem-resistant Salmonella enterica. Drug Resist Updat. 2023;68:100953. doi:10.1016/j.drup.2023.100953
   PubMed Web of Science ®Google Scholar
• Ruan Z, Feng Y. BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res. 2016;44(D1):D682–D687. doi:10.1093/nar/gkv1004
   PubMed Web of Science ®Google Scholar
• Feng Y, Zou S, Chen H, Yu Y, Ruan Z. BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking. Nucleic Acids Res. 2021;49(D1):D644–D560. doi:10.1093/nar/gkaa821
   PubMed Web of Science ®Google Scholar
• Eugenin EA. Community-acquired pneumonia infections by Acinetobacter baumannii: how does alcohol impact the antimicrobial functions of macrophages?. Virulence. 2013;4(6):435–436. doi:10.4161/viru.25747
   PubMed Web of Science ®Google Scholar
• Iwasawa Y, Hosokawa N, Harada M, et al. Severe community-acquired pneumonia caused by Acinetobacter baumannii successfully treated with the initial administration of meropenem based on the sputum gram staining findings. Intern Med. 2019;58(2):301–305. doi:10.2169/internalmedicine.0787-18
   PubMed Web of Science ®Google Scholar
• Xu A, Zhu H, Gao B, et al. Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report. BMC Infect Dis. 2020;20(1):45. doi:10.1186/s12879-019-4733-5
   PubMed Web of Science ®Google Scholar
• Serota DP, Sexton ME, Kraft CS, Palacio F. Severe community-acquired pneumonia due to Acinetobacter baumannii in North America: case report and review of the literature. Open Forum Infect Dis. 2018;5(3):ofy044. doi:10.1093/ofid/ofy044
   PubMed Web of Science ®Google Scholar
• Ababneh Q, Abu Laila S, Jaradat Z. Prevalence, genetic diversity, antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from urban environments. J Appl Microbiol. 2022;133(6):3617–3633. doi:10.1111/jam.15795
   PubMed Web of Science ®Google Scholar
• Meumann EM, Anstey NM, Currie BJ, et al. Genomic epidemiology of severe community-onset Acinetobacter baumannii infection. Microb Genom. 2019;5(3):e000258. doi:10.1099/mgen.0.000258
   PubMed Web of Science ®Google Scholar
• Li T, Yang Y, Yan R, et al. Comparing core-genome MLST with PFGE and MLST for cluster analysis of carbapenem-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2022;30:148–151. doi:10.1016/j.jgar.2022.06.014
   PubMed Web of Science ®Google Scholar
• Mabrouk A, Chebbi Y, Raddaoui A, et al. Clonal spread of PER-1 and OXA-23 producing extensively drug resistant Acinetobacter baumannii during an outbreak in a burn intensive care unit in Tunisia. Acta Microbiol Immunol Hung. 2020;67(4):222–227. doi:10.1556/030.2020.01208
   PubMed Web of Science ®Google Scholar
• Sawant AR, Pagal S, Amar AK, et al. Coexistence of blaNDM-1, blaOXA-51, blaOXA-23, and armA in conjunction with novel mutations detected in RND efflux pump regulators in tigecycline resistant clinical isolates of Acinetobacter baumannii. Pathog Dis. 2022;80(1):ftac020. doi:10.1093/femspd/ftac020
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ding F, Luo Y, et al. Distribution pattern of carbapenemases and solitary contribution to resistance in clinical strains of Acinetobacter baumannii. Ann Palliat Med. 2021;10(8):9184–9191. doi:10.21037/apm-21-1805
   PubMed Web of Science ®Google Scholar
• Geisinger E, Huo W, Hernandez-Bird J, Isberg RR. Acinetobacter baumannii: envelope determinants that control drug resistance, virulence, and surface variability. Annu Rev Microbiol. 2019;73(1):481–506. doi:10.1146/annurev-micro-020518-115714
   PubMedGoogle Scholar
• Asrat H, Samaroo-Campbell J, Ata S, Quale J. Contribution of iron-transport systems and β-lactamases to cefiderocol resistance in clinical isolates of Acinetobacter baumannii Endemic to New York City. Antimicrob Agents Chemother. 2023;67(6):e0023423. doi:10.1128/aac.00234-23
   PubMed Web of Science ®Google Scholar
• Cook-Libin S, Sykes EME, Kornelsen V, Kumar A, Richardson AR. Iron acquisition mechanisms and their role in the virulence of Acinetobacter baumannii. Infect Immun. 2022;90(10):e0022322. doi:10.1128/iai.00223-22
   PubMed Web of Science ®Google Scholar